For updates on the latest in molecular targeted imaging for prostate cancer, join our community: [ Ссылка ]
Geoffrey B. Johnson, MD, PhD, discusses the appropriate use of PSMA PET in clinical practice. He emphasizes the significance of PSMA PET as an advanced imaging technique for prostate cancer. Dr. Johnson explores the different types of prostate cancer PET radiotracers, including the newly FDA-approved PSMA imaging agent, and compares them to conventional imaging methods such as MRI and CT.
You can also see more on our Imaging for Prostate Cancer learning center: [ Ссылка ]
